Mr. Marius Laubscher

Marius Laubscher is a clinical researcher in pediatric infectious diseases based in South Africa, with a strong focus on respiratory viral infections and vaccine-preventable illnesses in children. His work is closely linked to hospital-based surveillance platforms and collaborative global research networks, contributing to high-impact studies published in leading medical journals.

His research centers on respiratory syncytial virus, influenza, pneumococcal disease, and SARS-CoV-2, particularly among vulnerable populations such as preterm infants and HIV-exposed children. He has advanced understanding of RSV disease burden, long-term pulmonary sequelae, monoclonal antibody targets, and shifts in pathogen circulation during the COVID-19 pandemic.

Laubscher has also contributed to pivotal vaccine trials and effectiveness studies, including evaluations of COVID-19 and influenza vaccines and optimized pneumococcal schedules. His work integrates epidemiology, clinical outcomes, and immunization strategy, informing maternal and early childhood prevention policies in high-burden settings.